Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
Human Mutation|May 18, 2004
Identification of a functional mutation in pp32r1 (ANP32C)G John Kochevar, Jonathan R Brody, ShriHari S Kadkol, et al.
Cancer|February 8, 2022
Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongsClaymore C Kills First, Thomas L Sutton, Jackilen Shannon, et al.
Cancer Research|October 5, 2006
Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapyJonathan R Brody, Tomas Hucl, Eike Gallmeier, et al.
Nature Cancer|February 5, 2022
Envisioning the future of precision oncology trialsSubha Madhavan, Robert A Beckman, Matthew D McCoy, et al.
The American Journal of Pathology|December 26, 2003
pp32 reduction induces differentiation of TSU-Pr1 cellsJonathan R Brody, Shrihari S Kadkol, M Claire Hauer, et al.
Molecular Cancer Research : MCR|May 22, 2021
Stromal-Derived Extracellular Vesicles Suppress Proliferation of Bone Metastatic Cancer Cells Mediated by ERK2Alison B Shupp, Manish Neupane, Lebaron C Agostini, et al.
BMC Genetics|January 19, 2006
Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancersMichiel S van der Heijden, Jonathan R Brody, Elhaam Elghalbzouri-Maghrani, et al.
Cancer Research|October 3, 2007
High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motifTomas Hucl, Jonathan R Brody, Eike Gallmeier, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 3, 2011
Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literatureDavid W Rittenhouse, Vanessa A Talbott, Zafia Anklesaria, et al.
Journal of the American College of Surgeons|May 13, 2008
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detectionAgnes Witkiewicz, Timothy K Williams, Joseph Cozzitorto, et al.
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
Human Mutation|May 18, 2004
Identification of a functional mutation in pp32r1 (ANP32C)G John Kochevar, Jonathan R Brody, ShriHari S Kadkol, et al.
Cancer|February 8, 2022
Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongsClaymore C Kills First, Thomas L Sutton, Jackilen Shannon, et al.
Cancer Research|October 5, 2006
Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapyJonathan R Brody, Tomas Hucl, Eike Gallmeier, et al.
Nature Cancer|February 5, 2022
Envisioning the future of precision oncology trialsSubha Madhavan, Robert A Beckman, Matthew D McCoy, et al.
The American Journal of Pathology|December 26, 2003
pp32 reduction induces differentiation of TSU-Pr1 cellsJonathan R Brody, Shrihari S Kadkol, M Claire Hauer, et al.
Molecular Cancer Research : MCR|May 22, 2021
Stromal-Derived Extracellular Vesicles Suppress Proliferation of Bone Metastatic Cancer Cells Mediated by ERK2Alison B Shupp, Manish Neupane, Lebaron C Agostini, et al.
BMC Genetics|January 19, 2006
Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancersMichiel S van der Heijden, Jonathan R Brody, Elhaam Elghalbzouri-Maghrani, et al.
Cancer Research|October 3, 2007
High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motifTomas Hucl, Jonathan R Brody, Eike Gallmeier, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 3, 2011
Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literatureDavid W Rittenhouse, Vanessa A Talbott, Zafia Anklesaria, et al.
Journal of the American College of Surgeons|May 13, 2008
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detectionAgnes Witkiewicz, Timothy K Williams, Joseph Cozzitorto, et al.
Pageof 17